Understanding the impact of DNA damage repair (DDR) abnormalities in prostate cancer progression.
Understanding the roles of germline variations in antioxidant, hormone signaling, and hormone transporters in prostate cancer development and progression.
Understanding mechanisms of resistance to androgen deprivation therapy, enzalutamide, abiraterone, docetaxel and PARP inhibitors.
Understanding the role of non-coding RNAs (including miRNAs, LncRNAs, and NC sponge mechanism) in prostate cancer development and progression.
Understanding how androgen transporters (SLCO family) participate in progression of prostate cancer and resistance mechanisms.
Investigating the effect of Y-chromosome loss in castration-resistant prostate cancer (CRPC) progression.
Understanding the role of transcription factors in aggressive prostate cancer.
Understanding the role of cholesterol metabolism in progression of Localized prostate cancer to a lethal disease